AR in the OR: A New Vision for High-Precision Knee Replacement Surgery

BESANÇON, France – March 24, 2026 – A year after French medtech pioneer Pixee Medical announced the CE mark for its Knee+ NexSight augmented reality system, the technology is solidifying its place as a significant disruptor in orthopedic surgery. The initial European launch, which began with a handful of procedures, has since been eclipsed by a successful entry into the competitive U.S. market, signaling a potential paradigm shift away from bulky, expensive surgical robots toward more agile, cost-effective solutions.

Today's anniversary of the European milestone highlights the rapid momentum of a technology that promises robotic-level accuracy in the form of a pair of glasses. Knee+ NexSight, an AR guidance platform for total knee arthroplasty, was designed to address critical pain points in modern orthopedics: the need for precision, efficiency, and cost control. After receiving its CE mark, the company quickly secured a 510(k) clearance from the U.S. Food and Drug Administration in April 2025, with the first American procedure performed just weeks later, confirming the global appetite for such innovation.

Redefining Surgical Precision

At the heart of Pixee Medical's innovation is the fusion of the digital and physical worlds directly in the surgeon's line of sight. The Knee+ NexSight system projects critical information, including instrument tracking and virtual alignment guides, onto the operative field through a lightweight headset. This allows surgeons to see real-time data overlaid on the patient's anatomy, enabling precise bone cuts and implant positioning without having to look away at a separate screen or rely on cumbersome mechanical guides.

The system is enhanced with voice command functionality, allowing for a hands-free, sterile workflow. “Knee+ NexSight is not just an incremental update; it is a new way to think about AR guidance in high-volume environments,” said Sébastien Henry, CEO of Pixee Medical, in the original announcement. “It brings the accuracy of a robot in the form factor of a pair of glasses - without heavy infrastructure, without pre-operative imaging, and without disposables.”

This approach is backed by clinical data suggesting the technology delivers on its promises. Studies have shown that AR-assisted knee replacements can improve alignment and even reduce peri-operative blood loss. The company's claim of achieving “robotic-level accuracy” is a direct challenge to the current market leaders, suggesting that the same or better outcomes can be achieved with a fraction of the complexity and cost.

Democratizing the High-Tech Operating Room

The most profound impact of technologies like Knee+ NexSight may be economic. The orthopedic surgical market has been increasingly dominated by robotic platforms from giants like Stryker and Zimmer Biomet. While these systems are highly effective, their multi-million-dollar price tags, dedicated consumables, and large physical footprints place them out of reach for many smaller hospitals and ambulatory surgical centers (ASCs).

This is where Pixee Medical is carving out a crucial niche. By eliminating the need for a robot, a dedicated console, and costly single-use disposables, Knee+ NexSight dramatically lowers the barrier to entry for advanced surgical guidance. The system is also implant-agnostic, giving surgeons the flexibility to use their preferred knee systems. This financial and operational accessibility is particularly vital for the rapidly growing ASC market in the U.S., where efficiency and cost-effectiveness are paramount.

Furthermore, the system is designed to integrate seamlessly into existing surgical workflows, often without adding operative time compared to conventional techniques. It also sidesteps the need for costly and radiation-intensive pre-operative CT scans that many robotic systems require for planning. For healthcare administrators grappling with tight budgets, the value proposition is clear: a tool that enhances surgical precision and potentially improves patient outcomes while simultaneously reducing capital expenditure and per-procedure costs.

A Surgeon-Centric Design

Beyond the technological and economic benefits, the adoption of Knee+ NexSight has been driven by its surgeon-centric design. Early adopters have praised the system for its intuitive nature and minimal learning curve. The ability to maintain focus on the patient while receiving dynamic guidance is a significant ergonomic and cognitive advantage.

“This new version provides clear gains in speed, precision, and comfort during the procedure,” noted Dr. Vidal, an orthopedic surgeon at Langres Hospital in France and an early user of the technology. “It fits naturally into my surgical workflow and gives me strong confidence when planning and performing my bone cuts.”

This sentiment has been echoed by surgeons in the United States. One surgeon who performed some of the first FDA-cleared procedures described the system as being as accurate as any robotic platform but far more intuitive and efficient, perfectly fitting the pace and practical realities of outpatient surgery. The technology empowers surgeons to execute personalized alignment strategies, including kinematic alignment, which aims to restore the patient's unique, natural knee motion. This level of personalization, combined with high precision, is key to improving long-term patient satisfaction and function.

With its first-generation products already used in over 10,000 procedures worldwide, Pixee Medical has established a strong foundation of clinical use and trust. The company's growth has been bolstered by a $15 million Series B funding round in early 2024, which was earmarked to accelerate its U.S. expansion and further product development. As operating rooms become increasingly data-driven, Knee+ NexSight's connected architecture, which allows for remote software updates and integration with other digital platforms, positions Pixee Medical not just as a device manufacturer, but as a key player in the future of connected, intelligent surgery.